Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myeloid cell activity encompasses the diverse functions carried out by immune cells derived from the myeloid lineage—including monocytes, macrophages, granulocytes (neutrophils, eosinophils, basophils), dendritic cells, and mast cells. These cells are central to innate immunity, mediating pathogen clearance through phagocytosis, orchestrating inflammation via cytokine production, presenting antigens to adaptive immune cells, and participating in tissue repair[5][1][4]. Dysregulation of myeloid cell activity contributes to a wide range of diseases such as cancer, autoimmunity, and chronic inflammation[2][3][5]. The molecular mechanisms controlling myeloid cell activity involve complex receptor-mediated signaling pathways and metabolic cues, but the term "myeloid cell activity" itself does not designate a single molecular target amenable to direct therapeutic intervention[1][4].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myeloid cell activity.